In addition, in hepatocellular carcinoma (HCC) and lung adenocarcinoma, OPA1 expression determines the response to chemotherapeutics, and OPA1 knockdown sensitizes cells to the treatment. This evidence concerns the gene OPA1 and lung adenocarcinoma.